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Toxoplasma gondii is a protozoan parasite that infects humans and animals via congenital or postnatal
routes. During parasite infection, IL-10-producing Bregs are stimulated as part of the parasite-induced
host immune responses that favor infection. In this study, we investigated whether T. gondii infection
induces immune regulatory cells including IL-10-producing CD1dhighCD5þ regulatory B cells (Bregs) and
whether Breg induction is critical for the development of chronic infection of T. gondii. Furthermore, B
cell-deﬁcient (μMT) mice revealed that the IL-10-producing B cells might be associated with the de-
velopment of chronic T. gondii infection. To better understand the mechanism underlying the accumu-
lation of IL-10-producing B cells upon T. gondii infection, we determined the effect of products released
by T. gondii on the induction and differentiation of IL-10-producing B cells during the acute stage of
infection using transgenic green ﬂuorescent protein (GFP)-expressing T. gondii strain. We demonstrated
that products secreted at the stage of cell lysis by fully replicated tachyzoites induced the differentiation
of naive B cells to IL-10-producing Bregs. Our results indicated that the downregulation of the immune
response via Bregs during T. gondii infection is related to cyst formation in the host brain and to the
establishment of chronic infection.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Toxoplasma gondii is an intracellular protozoan parasite with a
worldwide distribution that infects a variety of warm-blooded
mammals and causes toxoplasmosis, one of the most common
chronic parasitic infections in humans: approximately one-third of
the world population carries T. gondii [1]. Toxoplasmosis is usually
clinically asymptomatic in healthy individuals but it can lead to severe
complications in pregnant women and immunocompromised pa-
tients. The life cycle of T. gondii includes two asexual stages: rapidly
dividing tachyzoites are found in the spleen and non-lymphoid tis-
sues in the ﬁrst week of infection and deﬁne the acute phase, whereas
slowly dividing bradyzoites, residing mainly inside tissue cysts in the
brain, appear around the second week and mark the beginning of the
chronic phase [2]. Acute infection is characterized by tachyzoite
proliferation and is known to cause lymphadenitis and congenital
infection of fetuses [3]. During chronic infection, the parasite forms
cysts, preferentially in the brain, and this phase is characterized by the
balance between host immune responses and the parasite immune
evasion.an open access article under the CParasites employ various strategies to evade host immune re-
sponses that normally thwart infection. The establishment and
maintenance of chronic infection involves a balance between host
immunity and parasite evasion of the immune response [4]. Al-
though immune evasion supposedly evolved to favor parasite es-
tablishment within the host, some particular immune-escaping
strategies might, quite paradoxically, be beneﬁcial for the host [5].
Regulatory B cells (Bregs), regulatory T cells (Tregs), and alter-
natively activated macrophages have been identiﬁed as key com-
ponents of the immune regulatory network functioning during
helminth infections [6–8]. These immunoregulatory cells expand
during parasite infection and may promote the development of
chronic infection and parasite survival, as well as inﬂuence un-
related immune-driven pathology such as allergy and auto-
immune diseases [7,9].
B cells typically function as antibody-producing cells but they
are also involved in other immune functions including cytokine
and chemokine secretion and antigen presentation. In addition, IL-
10-producing B cells have been shown to participate in the in-
duction of immune tolerance and the suppression of inﬂammation
[9–11]. The IL-10-producing subset of Bregs was ﬁrst demonstrated
to play a critical role in limiting disease severity in autoimmune
conditions [6]. In recent studies, it has been found that these Bregs
are also signiﬁcantly induced during parasite infection [6,12–14].C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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IL-10-producing Bregs are stimulated as part of the parasite-in-
duced host immune responses that favor infection [13,14]. Indeed,
blockade of these Bregs increased host resistance and reduced
parasite burden, while also increasing immune-driven pathology
[13,14]. Interestingly, IL-10-producing B cells induced by parasite
infection have been shown to suppress allergic inﬂammatory and
autoimmune diseases. In animal models, various helminths alle-
viated the symptoms of experimental allergic and autoimmune
diseases via the induction of IL-10-producing B cells [12,15–17].
These results have prompted clinical trials in which the in-
troduction of live helminths to treat patients with autoimmune
diseases was tested [18]. However, the clear understanding of the
complex cellular mechanism that regulates the host immune re-
sponse to parasitic infections through the activation of the im-
mune regulatory network remains a key issue in the prevention
and control of immune-mediated diseases.
T. gondii causes the induction of strong cell-mediated immunity
characterized by a highly polarized Th1 response in the early
stages of infection. IFN-γ-dependent, cell-mediated immunity is
the major host resistance mechanism against chronic T. gondii
infection [19]. Recent studies have reported that IL-10-producing
CD1dhighCD5þ B cells suppress the IFN-γ production and type
1 immune responses during intracellular bacterial infection [20].
In addition, chronic graft-versus-host disease-derived T cells cul-
tured with IL-10-producing Bregs showed signiﬁcantly reduced
IFN-γ release, suggesting that these Bregs might be deeply in-
volved in IFN-γ-dependent immunity [21]. However, the role of IL-
10-producing B cells in the course of T. gondii infection is poorly
understood.
The aim of this study was to investigate the inﬂuence of T.
gondii infection on the accumulation of IL-10-producing
CD1dhighCD5þ B cell as immune regulatory cells.2. Materials and methods
2.1. Ethics statement
The study were reviewed and approved by the Korean Centers
for Disease Control and Prevention and the Institutional Animal
Care and Use Committee (KCDC-IACUC; approval number KCDC-
12-039-2A). All experimental and animal care protocols were
performed in accordance with the guideline for the Care and Use
of Laboratory Animals of the Korean Centers for Disease Control
and Prevention. Pathogen-free6- to 7-week-oldfemale C57BL/6
mice were purchased from Orient Bio (Korea). B cell-deﬁcient mMT
(B6.129S2-Igh-6tm1Cgn/J) mice were obtained from Jackson La-
boratory (Bar Harbor, ME, USA), and housed in a speciﬁc pathogen-
free facility in individually ventilated and ﬁltered cages. For in vivo
studies, mice were anesthetized by 2% isoﬂurane in 0.3 L/min
oxygen inhalation during the procedure. The adequacy of an-
esthesia was monitored by disappearance of pedal withdrawal
reﬂex. For ex vivo studies, mice were euthanized by cervical dis-
location. The adequacy of sacriﬁce was monitored from the dis-
appearance of heart beat and breath.
2.2. Parasites and infection
Cysts of the T. gondiiME49 strain were obtained from the brains
of chronically infected mice: mMT and control mice were infected
with 15 cysts intraperitoneally and the brains were removed at
indicated days after infection and homogenized with 1 mL of
Dulbecco's phosphate-buffered saline (Gibco/Life Technologies,
Grand Island, NY, USA) by using a 23-gauge needle. The brain cysts
were examined in 20-mL brain homogenates mounted on glassslides by using a light microscope at a magniﬁcation of 20 and
the total number of cysts was determined in ﬁve 20-mL per sample.
For the identiﬁcation of the exact stage of the parasite lytic cycle,
we a used transgenic green ﬂuorescent protein (GFP)-expressing T.
gondii strain generated by Prof. Yoshifumi Nishikawa (National
Research Center for Protozoan Diseases, Obihiro University of
Agriculture and Veterinary Medicine, Japan). GFP-positive T. gondii
tachyzoites were kindly provided by Dr. Young-Ha Lee (Chungnam
National University School of Medicine, Korea). HeLa cells (ATCC,
Manassas, VA, USA) were inoculated with GFP-positive T. gondii
tachyzoites at a multiplicity of infection of 1:6 for 3 days and su-
pernatants containing excretory/secretory products (ESPs) re-
leased during T. gondii infection were collected at 4, 24, 48, and
72 h post-infection. After centrifugation for 5 min at 6000 rpm, the
protein concentration in the ESP-containing supernatants was
determined using the Bradford assay and the samples were stored
at 70 °C until use.2.3. Antibodies and ﬂow cytometry
Splenocytes were isolated using a 40-mm nylon cell strainer (BD
Biosciences, San Jose, CA, USA); RBCs were lysed with buffer
containing 0.14 NH4Cl and 0.017 M Tris-base (pH 7.5). IL-10-pro-
ducing CD1dhighCD5þCD19þ Bregs were analyzed by ﬂow cyto-
metry after immunostaining of surface markers with the following
monoclonal antibodies: ﬂuorescein isothiocyanate (FITC)-con-
jugated anti-CD19 (clone 1D3) (BD Biosciences, San Jose, CA, USA),
phycoerythrin (PE)-conjugated anti-CD1d (clone 1B1; isotype, Rat
IgG2b, κ) (BD Biosciences), allophycocyanin (APC)-conjugated
anti-CD5 (clone 53–7.3) (eBioscience, San Diego, CA, USA), and
peridinin chlorophyll-protein complex (PerCP)- or PE-conjugated
anti-IL-10 (clone JES5–16E3) (eBioscience). For subsequent in-
tracellular IL-10 staining, the Cytoﬁx/Cytoperm kit (BD Bios-
ciences) was used according to the manufacturer's protocol (BD
Biosciences). Intracellular transport processes were inhibited with
BD GolgiStop containing the transport inhibitor monesin and Fc
receptors were blocked by treatment with rat anti-mouse CD16/32
antibody (BD Bioscience) for 15 min. The FlowJo software (Tree
Star Inc., Ashland, OR, USA)was used to analyze the ﬂow cytometry
data. To determine background staining, non-reactive isotype-
matched control monoclonal antibodies (eBioscience) were used
and cells were gated to exclude Z98% of non-reactive cells.2.4. B cell isolation and stimulation
The regulatory B cell isolation kit (Miltenyi Biotech) was used to
purify naive CD19þ B cells according to the manufacturer's in-
structions. For analysis of the cytokine production, 4105 puriﬁed
CD19þ B cells were cultured with ESPs, total lysate of T. gondii
tachyzoites, or LPS (Escherichia coli serotype 0111:B4, Sigma-Al-
drich, St. Louis, MO, USA) for 24 h. Culture supernatant was col-
lected to assess the cytokine production, and the cells were ana-
lyzed by ﬂow cytometry.2.5. Statistical analysis
Statistical analyses were performed with the GraphPad Prism
v.3 software. All data are shown as the mean 7 SD. The sig-
niﬁcance of the differences between sample means was de-
termined using Student's t-test or with one-way ANOVA followed
by Bonferroni's post-test for multiple comparisons. A P-value
o0.05 was considered signiﬁcant.
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3.1. IL-10-producing B cells are increased during T. gondii infection
Our previous study and another recent study demonstrated
that IL-10 production by B cells is required for host susceptibility
to protozoan parasite infection [13,14]. To determine whether
these B cells are induced by T. gondii infection, the IL-10 produc-
tion by B cells in T. gondii-infected and uninfected control mice
was veriﬁed by direct intracellular cytokine staining. At day 15
post-infection, the ratio to total B cells and the total number of
spleen IL-10-producing B cells was higher in infected mice than in
uninfected mice (Po0.01) (Fig. 1A). It has been shown that IL-10-
producing B cells function as Bregs with the CD1dhighCD5þCD19þ
phenotype [12,22]. Therefore, we examined the cell phenotype to
formally identify the IL-10-producing B cell subpopulation. As
expected, the majority of IL-10þCD19þ spleen cells expanded in
response to T. gondii infection exhibited the CD1dhigh CD5þ phe-
notype (Fig. 1B). To conﬁrm the increase in these regulatory im-
mune cells during T. gondii infection, we monitored the dynamics
of the IL-10-producing B cell subpopulation during the stage of
cyst formation in the brain, which is characteristic of chronic in-
fection. A large number of cysts with increased size in the brain
and the increased population of IL-10-producing B cells in the9.97%
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Fig. 1. Identiﬁcation of IL-10-producing CD1dhighCD5þCD19þ Bregs induced by T. gondii
day 15 post-infection. To detect IL-10-producing B cells, splenocytes were stained with a
initial gate for identifying B cells. (A) Analysis of IL-10-producing B cell population (le
produced IL-10 in the spleen of uninfected and infected mice. (B) The gating strategy u
IL-10þCD1dhighCD5þ B cells is expressed as the mean7SD. Cells from 5 mice per group w
vs. uninfected control mice (Student's t-test).spleen were observed in chronically infected mice, respectively.
(Fig. 2). These data demonstrated that T. gondii infection induces
the accumulation of IL-10-producing Bregs.
3.2. Cyst formation during T. gondii infection is markedly suppressed
in B cell-deﬁcient mice
To investigate whether the induction of IL-10-producing B cells
could facilitate cyst formation, we used mMT mice that lack mature
B cells. By using ﬂow cytometry, we conﬁrmed that B cells with
the CD5þCD1dþCD19þ phenotype were not present in these mice
(Fig. 3A). C57BL/6 wild-type control and mMT mice were infected
with T. gondii and monitored for brain cyst burden. Comparison of
the course of T. gondii infection in age- and sex-matched mMT and
C57BL/6 wild-type mice revealed that the number of cysts was
4-fold lower in the mMT mice than in the control mice (Po0.001)
(Fig. 3B). Spleen enlargement is a typical symptom of protozoal
infection such as toxoplasmosis. However, infected mMT mice de-
monstrated smaller spleens than the wild-type mice (Fig. 3C).
T. gondii is known to induce an antigen-speciﬁc type 1 T cell
immune response in the infected host [23]. In addition, analysis of
the Th1/Th2-associated serum cytokines showed that the levels of
IFN-γ and TNF-α increased in the T. gondii-infected mMT mice. In
contrast, IL-10 production was considerably lower in these mice18.4%
T. gondii -infected 
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ft panels). The bar graphs indicate the ratio (%) and total numbers of B cells that
sed to identify IL-10-producing CD1dhighCD5þ B cell is shown. The proportion of
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Fig. 2. Cyst formation and Breg accumulation during T. gondii infection. Mice were infected with 15 T. gondii cysts by intraperitoneal injection and sacriﬁced at the indicated
time points. (A) The brain was analyzed for cyst burden. Cysts in the brain were observed under a light microscope (magniﬁcation 20 ; upper panels). The graph presents
the dynamics of cyst formation in the brain during the course of infection. (B) The spleen were analyzed populations of immunoregulatory cells. The IL-10þ Breg population
was monitored during the acute and chronic stages of infection. Bars graphs represent the mean7SD (n¼5) and data are representative of 2 independent experiments with
comparable results.
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between the levels of IL-5 and IL-13 in wild-type and mMT mice
(Fig. 3D). Taken together, although the complete absence of B cells
is not the same as the absence of IL-10-secreting B cells, these
results indirectly suggested that IL-10-producing B cells maybe
involved in T. gondii pathogenesis and in Treg accumulation fol-
lowing parasite infection.
3.3. Effect of parasite-derived ESPs released during different stages of
T. gondii infection on the induction of IL-10-producing B cells
To better understand the mechanism underlying the accumu-
lation of IL-10-producing B cells upon T. gondii infection, we ex-
amined the effect of ESPs released by T. gondii on the induction
and differentiation of IL-10-producing B cells during the acute
stage of infection. Toxoplasma can infect and replicate within vir-
tually any nucleated mammalian cell; its lytic cycle includes host
cell attachment and invasion, intracellular vacuole formation, and
parasite replication and egress [24]. To identify distinct stages of
the parasite's lytic cycle, we monitored the infection of HeLa cells
with GFP-expressing T. gondii (Fig. 4A). ESP-containing cell su-
pernatants were harvested at different infection stages and used to
treat naive CD19þB cells isolated from the spleens of uninfected
mice and the effect of the ESPs on the differentiation of naive B
cells into IL-10-producing cells was determined after 24 h by ﬂow
cytometry. Culture supernatants of uninfected cells, LPS, or med-
ium alone were used as controls. Among the ESPs obtained at
different infection stages, the fraction collected at the stage of celllysis and release of T. gondii tachyzoites, at 72 h after inoculation,
was the most potent in enhancing the differentiation of naive B
cells into IL-10-producing CD5þCD1highCD19þ Bregs (Fig. 4B and
C). It should be noted that B cell differentiation was not induced by
stimulation with the T. gondii total lysate and was only slightly
induced by live tachyzoites (Supplementary Fig. S1).4. Discussion
The development of chronic parasite infection is believed to
result from the suppression of host immune responses. As T. gondii
infection is usually chronic, it is likely that the parasite modulates
the host immune system to prevent its own destruction. The
ﬁndings in this study indicated that the induction of IL-10-pro-
ducing Bregs in response to T. gondii infection may play an im-
portant role in the development of chronic infection as a part of
the parasite evasion strategy against host immune mechanisms
(Fig. 5).
We observed that a signiﬁcant increase of the IL-10-producing
CD1highCD5þCD19þ Breg subset during T. gondii infection was
accompanied by increased cyst formation in the brain, which is a
characteristic feature of chronic T. gondii infection (Figs. 2A and B).
To investigate indirectly the relationship between the induction of
IL-10-producing B cells and the facilitation of cyst formation, we
used mMT mice that cannot generate mature IL-10-producing
CD1highCD5þCD19þ B cells (Fig. 3A). In this experiment, we ob-
served that T. gondii cyst formation in the brain of B cell-deﬁcient
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Fig. 3. Cyst formation in B cell deﬁcient mice was signiﬁcantly suppressed during T. gondii infection. (A) Identiﬁcation of the absence of Bregs in mMT mice. Splenocytes from
mMT and wild-type mice were stained with anti-mouse CD19, CD5, and CD1d antibodies and analyzed by ﬂow cytometry. Black and red histograms represent μMT and wild-
type mice, respectively. mMT and wild-type (WT) mice were infected with T. gondii. (A) The number of brain cysts 15 days post-infection. (B) Spleen enlargement in the
infected mice. (C) Analysis of serum cytokine levels in the infected mice. (D) Flow cytometric analysis after staining for CD25 and FoxP3 in gated spleen CD4þ T cells and the
ratio (%) of CD4þCD25þFoxP3þ T cells to total CD4þ T cells in the splenocytes. The results are expressed as the mean7SD (n¼5). *Po0.05 and ***Po0.001 vs. wild-type
mice.
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megaly, one of the classic features of toxoplasmosis, was moderate
in infected B cell-deﬁcient compared to wild-type mice (Fig. 3C).
Thus, these results suggest that the induction of IL-10-producing B
cells during T. gondii infection is critical for cyst formation and the
establishment of chronic parasite infection. These results provide
the ﬁrst evidence for the importance of IL-10-producing B cells in
the development of chronic T. gondii infection.
Furthermore, we shed light on the mechanism induced by
these Bregs to support chronic infection. The proliferation of ta-
chyzoites during the acute stage is important for the establish-
ment of chronic infection but is limited by the IFN-γ-dependent
host immune response [19]. We found that IL-10-producing B cells
contributed to the suppression of these cell-mediated immuneresponses as evidenced by the higher IFN-γ serum levels in the
mMT mice compared to wild mice (Fig. 3D).
Although several studies have reported Breg accumulation in
response to helminth infection, the data on protozoal infections
are limited and it is unclear whether parasite-derived molecules
affect the induction of IL-10-producing B cells. Thus, we studied
the effect of parasite-derived products secreted during different
stages of T. gondii infection on the induction of Bregs in vitro. T.
gondii, as an obligate intracellular pathogen, passes through four
distinct life cycle stages: attachment and invasion, formation of
the parasitophorous vacuole and intracellular growth, replication,
and lysis of the host cell and release of the parasites (Fig. 4A). We
demonstrated that the ESPs released at the stage of cell lysis by
fully replicated tachyzoites induced the differentiation of naive B
4 24 48 72 (hr) 
4 24 48 72 (hr) 
** 
* 
Un-infected 
Tg-infected 
Un-infected 
Tg-infected 
 
 
Fig. 4. IL-10-producing CD1dhighCD5þ Bregs are stimulated by T. gondii-infected cell supernatants. (A) Life cycle of T. gondii. For the identiﬁcation of the lytic cycle stage, HeLa
cells were inoculated at a multiplicity of infection of 1:6 with GFP-expressing T. gondii tachyzoites and incubated for 3 days, and tachyzoite transformation was monitored by
ﬂuorescent microscopy. Supernatants containing ESPs released during T. gondii infection were collected at 4, 24, 48, and 72 h post-infection and used to treat naive CD19þ B
cells isolated from wild-type mice for 24 h. LPS (1 μg/mL) and medium were used as positive and negative control, respectively. PV, parasitophorous vacuole. (B–C) To
quantify the IL-10þCD19þand CD1dhighCD5þCD19þ B cells after the treatment, the cells were stained with CD19, CD5, and CD1d antibodies or with the Rat IgG2b, κ isotype
control antibody. To detect intracellular IL-10, the cells were permeabilized and stained with IL-10 antibody or JES5-16E3 isotype control antibody. The ratio (%) of IL-10-
producing CD19þ or CD1dhighCD5þCD19þ B cells to total CD19þ B cells is presented. *Po0.05 and **Po0.01 compared with control group.
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Fig. 5. The mechanism pertaining to the role of IL-10 producing regulatory B cells
in T. gondii infection. The induction of IL-10-producing Bregs in response to T. gondii
infection modulates the host immune system to establish the chronic infection of
T. gondii.
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whether the ESP was from host or parasitic origin. This ﬁnding
indicated that the induction of IL-10-producing Bregs is enhanced
by host cell lysis and parasite release, and offers new insights into
the mechanism related to the differentiation and induction of IL-
10-producing B cells by parasite infection.
In this study, we demonstrated that a signiﬁcant accumulation
of the IL-10-producing CD1highCD5þCD19þ B cells subset was in-
duced during T. gondii infection. Although considerable works
have been conducted on the immune response to Toxoplasma,
there are no studies investigating the role of B cells subset with a
unique IL-10-producing CD1dhighCD5þ phenotype in this process.
Our results provided evidence that modulation of the immune
response via IL-10-producing B cells induced in the course of T.
gondii infection is related to the establishment of chronic infection
(Fig. 5).Acknowledgments
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